https://www.merck.com/news/ridgeback-biotherapeutics-and-merck-announce-preliminary-findings-from-a-phase-2a-trial-of-investigational-covid-19-therapeutic-molnupiravir/
Dr. Shepherd Medical Director Report 3-2021 Click Here for the Report CDPHE COVID-19 Update Presentation 2-24-2021
See full health advisory update ● CDPHE has been conducting ongoing surveillance for COVID-19 variants since December 2020, when the first case of B.1.1.7 in Colorado was announced.● As of…
Weekly new deaths among nursing home residents have decreased by 66% since long-term care vaccination efforts started at the end of December, compared to a 61% increase in all other…
The U.S. Food and Drug Administration found that Johnson & Johnson’s single-dose Covid-19 vaccine was 66.1% effective in preventing moderate to severe virus disease and appeared safe. The positive report…
Pfizer’s vaccine appears to reduce coronavirus transmission Vaccinated people tend to carry less virus in their bodies than unvaccinated people, studies show https://www.sciencenews.org/article/coronavirus-covid-19-pfizer-vaccine-may-reduce-transmission
https://pubmed.ncbi.nlm.nih.gov/29574073/ AbstractBackground: Compared to randomized controlled trials, nonexperimental studies often report larger survival benefits but higher rates of adverse events for statin use vs nonuse. Objective: We compared characteristics of…
A list of places for eligible persons to ge the COVID-19 Vaccine. It appears to be updated regularly. https://www.elpasocountyhealth.org/how-will-i-get-the-vaccine
https://www.medscape.com/viewarticle/945478?src=WNL_bom_210214_MSCPEDIT&uac=17637FN&impID=3191741&faf=1
https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html
